Analyst Ratings for ISIS Pharmaceuticals (ISIS) [Neutrals]

ISIS Rating Summary

ISIS Price Target Summary

* Over Last 12-Mos
  |   Expand Research on ISIS
Overall Rating: NEUTRAL   Rating Trend: Up   Avg. $ Target: $64.00 (+31.3%) * Over Last 12-Mos
Rating Score: 3.3 / 10   Percentile Rank: 29%
Date Firm Type Rating
(Past)
PT
(Past)
Start $ End $ % Chg. Details
3/2/2015 Stifel Downgrade Hold
(Buy)
N/A
(66.00)
68.56 48.75 -28.89% Details
2/4/2015 Piper Jaffray Downgrade Neutral
(Overweight)
68.00
(81.00)
64.70 48.75 -24.65% Details
Like ISIS Ratings? Also take a look at SNY, SAN, BIIB, RGLS

ISIS Ratings News